Muscarinic acetylcholine receptor 3 is dominant in myopia progression

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 10, 2012, Pages 6519-6525

  Lin, Hui Ju ^a   Wan, Lei ^a,b   Chen, Wen Chi ^a   Lin, Jane Ming ^a   Lin, Chao Jen ^c   Tsai, Fuu Jen ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CHRM1 PROTEIN, HUMAN; CHRM2 PROTEIN, HUMAN; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE COURSE; ECHOGRAPHY; EYE AXIS LENGTH; FEMALE; GENE STRUCTURE; GENETIC ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUSCARINIC RECEPTOR 1 GENE; MUSCARINIC RECEPTOR 2 GENE; MUSCARINIC RECEPTOR 3 GENE; MUSCARINIC RECEPTOR 4 GENE; MUSCARINIC RECEPTOR 5 GENE; MYOPIA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR GENE; REFRACTION ERROR; RISK; SYRIAN HAMSTER; VISUAL ACUITY; ANIMAL; CHROMOSOME MAP; DISEASE MODEL; DRUG ANTAGONISM; GENETIC PREDISPOSITION; GENETICS; HAMSTER; RISK FACTOR;

ADOLESCENT; ADULT; ANIMALS; ATROPINE; CHROMOSOME MAPPING; CRICETINAE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MESOCRICETUS; MUSCARINIC ANTAGONISTS; MYOPIA; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTOR, MUSCARINIC M4; RECEPTOR, MUSCARINIC M5; RECEPTORS, MUSCARINIC; RISK FACTORS; YOUNG ADULT;

EID: 84871895383     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-9031     Document Type: Article

References (45)

1. Au Eong KG, Tay TH, Lim MK. Race, culture and myopia in 110,236 young Singaporean males. Singapore Med J. 1993;34: 29-32.
2. Mavracanas TA, Mandalos A, Peios D, et al. Prevalence of myopia in a sample of Greek students. Acta Ophthalmol Scand. 2000;78:656-659.
3. Rose K, Smith W, Morgan I, Mitchell P. The increasing prevalence of myopia: implications for Australia. Clin Experiment Ophthalmol. 2001;29:116-120.
4. Seet B, Wong TY, Tan DT, et al. Myopia in Singapore: taking a public health approach. Br J Ophthalmol. 2001;85:521-526.
5. Shih YF, Chen CH, Chou AC, Ho TC, Lin LL, Hung PT. Effects of different concentrations of atropine on controlling myopia in myopic children. J Ocul Pharmacol Ther. 1999;15:85-90.
6. Fan DS, Lam DS, Chan CK, Fan AH, Cheung EY, Rao SK. Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study. Jpn J Ophthalmol. 2007;51:27-33.
7. McBrien NA, Moghaddam HO, Reeder AP. Atropine reduces experimental myopia and eye enlargement via a non accommodative mechanism. Invest Ophthalmol Vis Sci. 1993;34:205-215.
8. Barathi VA, Beuerman RW. Molecular mechanisms of muscarinic receptors in mouse scleral fibroblasts: prior to and after induction of experimental myopia with atropine treatment. Mol Vis. 2011;17:680-692.
9. McBrien NA, Jobling AI, Truong HT, Cottriall CL, Gentle A. Expression of muscarinic receptor subtypes in tree shrew ocular tissues and their regulation during the development of myopia. Mol Vis. 2009;15:464-475.
10. Lind GJ, Chew SJ, Marzani D, Wallman J. Muscarinic acetylcholine receptor antagonists inhibit chick scleral chondrocytes. Invest Ophthalmol Vis Sci. 1998;39:2217-2231.
11. Feldkamper M, Schaeffel F. Interactions of genes and environment in myopia. Dev Ophthalmol. 2003;37:34-49.
12. Zhang F, Gu W, Hurles ME, Lupski JR. Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet. 2009;10:451-481.
13. Wain LV, Armour JA, Tobin MD. Genomic copy number variation, human health, and disease. Lancet. 2009;374:340-350.
14. Glessner JT, Wang K, Cai G, et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009;459:569-573.
15. Noor A, Gianakopoulos PJ, Fernandez B, et al. Copy number variation analysis and sequencing of the X-linked mental retardation gene TSPAN7/TM4SF2 in patients with autism spectrum disorder. Psychiatr Genet. 2009;19:154-155.
16. Sutrala SR, Norton N, Williams NM, Buckland PR. Gene copy number variation in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:606-611.
17. Tam GW, Redon R, Carter NP, Grant SG. The role of DNA copy number variation in schizophrenia. Biol Psychiatry. 2009;66: 1005-1012.
18. Shlien A, Tabori U, Marshall CR, et al. Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome. Proc Natl Acad Sci U S A. 2008;105:11264-11269.
19. Venkatachalam R, Ligtenberg MJ, Hoogerbrugge N, Geurts van Kessel A, Kuiper RP. Predisposition to colorectal cancer: exploiting copy number variation to identify novel predisposing genes and mechanisms. Cytogenet Genome Res. 2008;123: 188-194.
20. Speleman F, Kumps C, Buysse K, et al. Copy number alterations and copy number variation in cancer: close encounters of the bad kind. Cytogenet Genome Res. 2008; 123:176-182.
21. Mamtani M, Anaya JM, He W, Ahuja SK. Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases. Genes Immun. 2010;11:155-160.
22. Bedrossian RH. The effect of atropine on myopia. Ophthalmology. 1979;86:713-719.
23. Lee JJ, Fang PC, Yang IH, et al. Prevention of myopia progression with 0.05% atropine solution. J Ocul Pharmacol Ther. 2006;22:41-46.
24. Fanciulli M, Norsworthy PJ, Petretto E, et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet. 2007;39: 721-723.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods. 2001;25:402-408.
26. Young TL, Ronan SM, Alvear AB, et al. A second locus for familial high myopia maps to chromosome 12q. Am J Hum Genet. 1998;63:1419-1424.
27. Farbrother JE, Kirov G, Owen MJ, Pong-Wong R, Haley CS, Guggenheim JA. Linkage analysis of the genetic loci for high myopia on 18p, 12q, and 17q in 51 U.K. families. Invest Ophthalmol Vis Sci. 2004;45:2879-2885.
28. Tang WC, Yip SP, Lo KK, et al. Linkage and association of myocilin (MYOC) polymorphisms with high myopia in a Chinese population. Mol Vis. 2007;13:534-544.
29. Jobling AI, Wan R, Gentle A, Bui BV, McBrien NA. Retinal and choroidal TGF-beta in the tree shrew model of myopia: isoform expression, activation and effects on function. Exp Eye Res. 2009;88:458-466.
30. Liang CL, Hsi E, Chen KC, Pan YR, Wang YS, Juo SH. A functional polymorphism at 3'UTR of the PAX6 gene may confer risk for extreme myopia in the Chinese. Invest Ophthalmol Vis Sci. 2011;52:3500-3505.
31. Inamori Y, Ota M, Inoko H, et al. The COL1A1 gene and high myopia susceptibility in Japanese. Hum Genet. 2007;122:151-157.
32. Teikari J, O'Donnell J, Kaprio J, Koskenvuo M. Genetic and environmental effects on oculometric traits. Optom Vis Sci. 1989;66:594-599.
33. Cerviño A, Hosking SL, Ferrer-Blasco T, Montes-Mico R, Gonzalez-Meijome JM. A pilot study on the differences in wavefront aberrations between two ethnic groups of young generally myopic subjects. Ophthalmic Physiol Opt. 2008;28: 532-537.
34. Jones-Jordan LA, Mitchell GL, Cotter SA, et al. Visual activity before and after the onset of juvenile myopia. Invest Ophthalmol Vis Sci. 2011;52:1841-1850.
35. Leader B, Leder P. Formin-2, a novel formin homology protein of the cappuccino subfamily, is highly expressed in the developing and adult central nervous system. Mech Dev. 2000; 93:221-131.
36. Gregory SG, Barlow KF, McLay KE, et al. The DNA sequence and biological annotation of human chromosome 1. Nature. 2006;441:315-321.
37. Schwendt M, McGinty JF. Regulator of G-protein signaling 4 interacts with metabotropic glutamate receptor subtype 5 in rat striatum: relevance to amphetamine behavioral sensitization. J Pharmacol Exp Ther. 2007;323:650-657.
38. Cuthbertson S, Zagvazdin YS, Kimble TD, et al. Preganglionic endings from nucleus of Edinger-Westphal in pigeon ciliary ganglion contain neuronal nitric oxide synthase. Vis Neurosci. 1999;16:819-834.
39. Luo X, Kranzler HR, Zuo L, Wang S, Blumberg HP, Gelernter J. CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case-control structured association study. Hum Mol Genet. 2005;14:2421-2434.
40. Leong WF, Chow VT. Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal differential cellular gene expression in response to enterovirus 71 infection. Cell Microbiol. 2006;8:565-580.
41. Omori Y, Imai J, Suzuki Y, Watanabe S, Tanigami A, Sugano S. OASIS is a transcriptional activator of CREB/ATF family with a transmembrane domain. Biochem Biophys Res Commun. 2002;293:470-477.
42. Fimia GM, Stoykova A, Romagnoli A, et al. Ambra1 regulates autophagy and development of the nervous system. Nature. 2007;447:1121-1125.
43. Liu Q, Wu J, Wang X, Zeng J. Changes in muscarinic acetylcholine receptor expression in form deprivation myopia in guinea pigs. Mol Vis. 2007;13:1234-1244.
44. Liu Q, Wu J, Wang XM, Zeng JW. Expression of 5 muscarinic receptor subtypes in the scleral tissue of immature guinea pigs [in Chinese]. Nan Fang Yi Ke Da Xue Xue Bao. 2007; 27:1327-1330.
45. Conrad DF, Pinto D, Redon R, et al. Origins and functional impact of copy number variation in the human genome. Nature. 2010;464:704-712.